BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37568905)

  • 1. Sentinel Lymph Node Biopsy in Prostate Cancer: An Overview of Diagnostic Performance, Oncological Outcomes, Safety, and Feasibility.
    Rossin G; Zorzi F; De Pablos-Rodríguez P; Biasatti A; Marenco J; Ongaro L; Perotti A; Tulone G; Traunero F; Piasentin A; Gomez-Ferrer A; Zucchi A; Trombetta C; Simonato A; Rubio-Briones J; Bartoletti R; Ramírez-Backhaus M; Claps F
    Diagnostics (Basel); 2023 Jul; 13(15):. PubMed ID: 37568905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Value, Oncologic Outcomes, and Safety Profile of Image-Guided Surgery Technologies During Robot-Assisted Lymph Node Dissection with Sentinel Node Biopsy for Prostate Cancer.
    Mazzone E; Dell'Oglio P; Grivas N; Wit E; Donswijk M; Briganti A; Leeuwen FV; Poel HV
    J Nucl Med; 2021 Oct; 62(10):1363-1371. PubMed ID: 33547208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel Node Procedure in Prostate Cancer: A Systematic Review to Assess Diagnostic Accuracy.
    Wit EMK; Acar C; Grivas N; Yuan C; Horenblas S; Liedberg F; Valdes Olmos RA; van Leeuwen FWB; van den Berg NS; Winter A; Wawroschek F; Hruby S; Janetschek G; Vidal-Sicart S; MacLennan S; Lam TB; van der Poel HG
    Eur Urol; 2017 Apr; 71(4):596-605. PubMed ID: 27639533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Adding Sentinel Node Biopsy to Extended Pelvic Lymph Node Dissection on Biochemical Recurrence in Prostate Cancer Patients Treated with Robot-Assisted Radical Prostatectomy.
    Grivas N; Wit EMK; Kuusk T; KleinJan GH; Donswijk ML; van Leeuwen FWB; van der Poel HG
    J Nucl Med; 2018 Feb; 59(2):204-209. PubMed ID: 28747519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and head-to-head comparison of three nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended and/or sentinel lymph node dissection.
    Grivas N; Wit E; Tillier C; van Muilekom E; Pos F; Winter A; van der Poel H
    Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2213-2226. PubMed ID: 28780722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel Lymph Node Biopsy in Prostate Cancer Patients: Results From an Injection Technique Targeting the Index Lesion in the Prostate Gland.
    Fumadó L; Abascal JM; Mestre-Fusco A; Vidal-Sicart S; Aguilar G; Juanpere N; Cecchini L
    Front Med (Lausanne); 2022; 9():931867. PubMed ID: 36117970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-Specific Membrane Antigen PET/CT Combined with Sentinel Node Biopsy for Primary Lymph Node Staging in Prostate Cancer.
    Hinsenveld FJ; Wit EMK; van Leeuwen PJ; Brouwer OR; Donswijk ML; Tillier CN; Vegt E; van Muilekom E; van Oosterom MN; van Leeuwen FWB; van der Poel HG
    J Nucl Med; 2020 Apr; 61(4):540-545. PubMed ID: 31562222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free-indocyanine green-guided pelvic lymph node dissection during radical prostatectomy.
    Claps F; de Pablos-Rodríguez P; Gómez-Ferrer Á; Mascarós JM; Marenco J; Collado Serra A; Casanova Ramón-Borja J; Calatrava Fons A; Trombetta C; Rubio-Briones J; Ramírez-Backhaus M
    Urol Oncol; 2022 Nov; 40(11):489.e19-489.e26. PubMed ID: 36175317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Value of Radio-Guided Sentinel Node Detection in Patients with Prostate Cancer Undergoing Radical Prostatectomy with Modified-Extended Lymphadenectomy.
    Małkiewicz B; Bugla B; Czarnecki M; Karwacki J; Długosz P; Gurwin A; Kiełb P; Lemiński A; Krajewski W; Jędrzejuk D; Bolanowski M; Hałoń A; Szydełko T
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291796
    [No Abstract]   [Full Text] [Related]  

  • 10. Pelvic lymph node dissection in prostate cancer.
    Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
    Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial.
    Lestingi JFP; Guglielmetti GB; Trinh QD; Coelho RF; Pontes J; Bastos DA; Cordeiro MD; Sarkis AS; Faraj SF; Mitre AI; Srougi M; Nahas WC
    Eur Urol; 2021 May; 79(5):595-604. PubMed ID: 33293077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study.
    Gandaglia G; Mazzone E; Stabile A; Pellegrino A; Cucchiara V; Barletta F; Scuderi S; Robesti D; Leni R; Samanes Gajate AM; Picchio M; Gianolli L; Brembilla G; De Cobelli F; van Oosterom MN; van Leeuwen FWB; Montorsi F; Briganti A
    Eur Urol; 2022 Oct; 82(4):411-418. PubMed ID: 35879127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging.
    Jeschke S; Lusuardi L; Myatt A; Hruby S; Pirich C; Janetschek G
    Urology; 2012 Nov; 80(5):1080-6. PubMed ID: 22990053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic lymph node dissection in prostate cancer: indications, extent and tailored approaches.
    Bianchi L; Gandaglia G; Fossati N; Suardi N; Moschini M; Cucchiara V; Bianchi M; Damiano R; Schiavina R; Shariat SF; Montorsi F; Briganti A
    Urologia; 2017 Feb; 84(1):9-19. PubMed ID: 26689534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic Sentinel Lymph Node Detection Using Fluorescence Imaging After Indocyanine Green Intravenous Injection in Colorectal Cancer: Protocol for a Feasibility Study.
    Liberale G; Vankerckhove S; Bouazza F; Gomez Galdon M; Larsimont D; Moreau M; Bourgeois P; Donckier V
    JMIR Res Protoc; 2020 Aug; 9(8):e17976. PubMed ID: 32554370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymph node staging with 68Ga-PSMA PET in patients with intermediate and high-risk prostate cancer suitable for radical prostatectomy managed in a prostate cancer unit.
    Maestroni UV; Campobasso D; Guarino G; Acampora A; Scarlattei M; Ziglioli F; Dinale F; Baldari G; Migliari S; Gasparro D; Ferretti S; Silini EM; Ruffini L
    Chin Clin Oncol; 2023 Jun; 12(3):22. PubMed ID: 37417288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence-supported lymphography and extended pelvic lymph node dissection in robot-assisted radical prostatectomy: a prospective, randomized trial.
    Harke NN; Godes M; Wagner C; Addali M; Fangmeyer B; Urbanova K; Hadaschik B; Witt JH
    World J Urol; 2018 Nov; 36(11):1817-1823. PubMed ID: 29767326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indocyanine Green Guided Pelvic Lymph Node Dissection: An Efficient Technique to Classify the Lymph Node Status of Patients with Prostate Cancer Who Underwent Radical Prostatectomy.
    Ramírez-Backhaus M; Mira Moreno A; Gómez Ferrer A; Calatrava Fons A; Casanova J; Solsona Narbón E; Ortiz Rodríguez IM; Rubio Briones J
    J Urol; 2016 Nov; 196(5):1429-1435. PubMed ID: 27235788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location-Based Oncological Outcomes of Sentinel Node Dissection in Radical Prostatectomy.
    Droghetti M; Ozman O; Berrens AC; Piazza P; Paccapelo A; van Vliet R; Schiavina R; Brunocilla E; Bekers E; Donswijk M; van Leeuwen FWB; van der Poel H
    J Urol; 2024 May; ():101097JU0000000000004051. PubMed ID: 38787799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in sentinel node dissection in prostate cancer from a technical perspective.
    Acar C; Kleinjan GH; van den Berg NS; Wit EM; van Leeuwen FW; van der Poel HG
    Int J Urol; 2015 Oct; 22(10):898-909. PubMed ID: 26173593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.